911½ñÈÕºÚÁÏ

Researchers in the Section of Metabolic Medicine conduct clinical studies in people living with all forms of diabetes. Our overarching aim is to improve prevention, treatment, and long-term health outcomes for individuals with diabetes. This is achieved through patient-centred clinical research, analysis of electronic health records, and population-based studies.

Our work spans four key areas of research:

Early-Onset Type 2 Diabetes

leads a team investigating the heterogeneity of early-onset type 2 diabetes across diverse ancestries, with the goal of advancing precision medicine approaches. Her team utilises population datasets and early-onset diabetes cohorts, including the MY DIABETES study, to better understand disease mechanisms and outcomes.

Type 1 Diabetes and the ADDRESS-2 Study

Our researchers coordinate ADDRESS-2, one of the largest cohorts of adults with newly diagnosed type 1 diabetes. This study has provided novel insights into the pathophysiology of type 1 diabetes, with ongoing research examining the role of viral infections in disease development. ADDRESS-2 is led by and .

Leveraging Real-World Data for Diabetes

, , and their team lead studies that apply real-world data to improve population health, inform healthcare interventions, and enhance diabetes care delivery across England. Their work ensures the effective implementation and quality assurance of targeted interventions at a national scale.

Diabetes Technology

 and lead research on emerging and existing technologies for diabetes management. Their studies focus on the application of continuous glucose monitoring, hybrid closed-loop systems, and digital health innovations to improve outcomes for people with type 1 and type 2.